NCT04864327 is a NA clinical trial of Brief smoking cessation advise in Smoking Cessation, sponsored by Kansaa A.Ibrahim.

Who is sponsoring NCT04864327?

NCT04864327 is sponsored by Kansaa A.Ibrahim.

What drugs are being tested in NCT04864327?

Interventions in NCT04864327: Brief smoking cessation advise.

What condition does NCT04864327 study?

NCT04864327 studies Smoking Cessation, Diabete Mellitus.

Is NCT04864327 still recruiting?

NCT04864327 is currently completed. Last updated 6 May 2021.

Last reviewed 2021-05-06 · How we verify

NCT04864327

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Smoking Intervention Among Patients With Diabetes

Completed NA Last updated 6 May 2021

What this trial tests

NA trial testing Brief smoking cessation advise in Smoking Cessation in 126 participants. Completed in 1 December 2012.

Timeline

5 May 2011

Primary endpoint
1 September 2012

1 December 2012

Quick facts

Lead sponsor	Kansaa A.Ibrahim
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	126
Start date	5 May 2011
Primary completion	1 September 2012
Estimated completion	1 December 2012
Sites	1 location across Iraq

Drugs / interventions tested

Brief smoking cessation advise

Conditions studied

Smoking Cessation — all drugs for Smoking Cessation →
Diabete Mellitus — all drugs for Diabete Mellitus →

Sponsor

Kansaa A.Ibrahim

Who can join

Eligibility, any sex, with Smoking Cessation or Diabete Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study determined the prevalence of tobacco smoking among patients with diabetes and evaluated the impact of a diabetes-specific tobacco cessation intervention on tobacco cessation outcomes and on the glycaemic control, blood pressure, lipid profile, complications, comorbidities and number of cigarettes consumed per day among the patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Impact of brief smoking cessation intervention on quitting rate and glycemic control in patients with diabetes: a randomized controlled trial.
Ibrahim AKA, Syed Sulaiman SA, Awaisu A, Shafie AA. · · 2023 · cited 5× · PMID 37890143 · DOI 10.1177/03000605231208598

Verify or expand the search:

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04864327 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kansaa A.Ibrahim
Last refreshed: 6 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04864327.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing